PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
CLOV vs. SPY
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between CLOV and SPY is 0.40, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.00.4

Performance

CLOV vs. SPY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Clover Health Investments, Corp. (CLOV) and SPDR S&P 500 ETF (SPY). The values are adjusted to include any dividend payments, if applicable.

0.00%50.00%100.00%150.00%200.00%SeptemberOctoberNovemberDecember2025
162.92%
13.66%
CLOV
SPY

Key characteristics

Sharpe Ratio

CLOV:

4.08

SPY:

1.88

Sortino Ratio

CLOV:

4.19

SPY:

2.52

Omega Ratio

CLOV:

1.50

SPY:

1.34

Calmar Ratio

CLOV:

3.52

SPY:

2.88

Martin Ratio

CLOV:

19.18

SPY:

11.98

Ulcer Index

CLOV:

17.84%

SPY:

2.02%

Daily Std Dev

CLOV:

83.92%

SPY:

12.78%

Max Drawdown

CLOV:

-97.19%

SPY:

-55.19%

Current Drawdown

CLOV:

-80.18%

SPY:

-1.30%

Returns By Period

In the year-to-date period, CLOV achieves a 39.37% return, which is significantly higher than SPY's 2.69% return.


CLOV

YTD

39.37%

1M

39.37%

6M

162.87%

1Y

339.00%

5Y*

N/A

10Y*

N/A

SPY

YTD

2.69%

1M

2.69%

6M

13.66%

1Y

24.60%

5Y*

15.11%

10Y*

13.37%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

CLOV vs. SPY — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

CLOV
The Risk-Adjusted Performance Rank of CLOV is 9797
Overall Rank
The Sharpe Ratio Rank of CLOV is 9999
Sharpe Ratio Rank
The Sortino Ratio Rank of CLOV is 9797
Sortino Ratio Rank
The Omega Ratio Rank of CLOV is 9595
Omega Ratio Rank
The Calmar Ratio Rank of CLOV is 9696
Calmar Ratio Rank
The Martin Ratio Rank of CLOV is 9797
Martin Ratio Rank

SPY
The Risk-Adjusted Performance Rank of SPY is 7878
Overall Rank
The Sharpe Ratio Rank of SPY is 7878
Sharpe Ratio Rank
The Sortino Ratio Rank of SPY is 7575
Sortino Ratio Rank
The Omega Ratio Rank of SPY is 7777
Omega Ratio Rank
The Calmar Ratio Rank of SPY is 7979
Calmar Ratio Rank
The Martin Ratio Rank of SPY is 8282
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

CLOV vs. SPY - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Clover Health Investments, Corp. (CLOV) and SPDR S&P 500 ETF (SPY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for CLOV, currently valued at 4.08, compared to the broader market-2.000.002.004.081.88
The chart of Sortino ratio for CLOV, currently valued at 4.19, compared to the broader market-4.00-2.000.002.004.004.192.52
The chart of Omega ratio for CLOV, currently valued at 1.50, compared to the broader market0.501.001.502.001.501.34
The chart of Calmar ratio for CLOV, currently valued at 3.52, compared to the broader market0.002.004.006.003.522.88
The chart of Martin ratio for CLOV, currently valued at 19.18, compared to the broader market-5.000.005.0010.0015.0020.0025.0019.1811.98
CLOV
SPY

The current CLOV Sharpe Ratio is 4.08, which is higher than the SPY Sharpe Ratio of 1.88. The chart below compares the historical Sharpe Ratios of CLOV and SPY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio0.001.002.003.004.005.00SeptemberOctoberNovemberDecember2025
4.08
1.88
CLOV
SPY

Dividends

CLOV vs. SPY - Dividend Comparison

CLOV has not paid dividends to shareholders, while SPY's dividend yield for the trailing twelve months is around 1.17%.


TTM20242023202220212020201920182017201620152014
CLOV
Clover Health Investments, Corp.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
SPY
SPDR S&P 500 ETF
1.17%1.21%1.40%1.65%1.20%1.52%1.75%2.04%1.80%2.03%2.06%1.87%

Drawdowns

CLOV vs. SPY - Drawdown Comparison

The maximum CLOV drawdown since its inception was -97.19%, which is greater than SPY's maximum drawdown of -55.19%. Use the drawdown chart below to compare losses from any high point for CLOV and SPY. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025
-80.18%
-1.30%
CLOV
SPY

Volatility

CLOV vs. SPY - Volatility Comparison

Clover Health Investments, Corp. (CLOV) has a higher volatility of 14.49% compared to SPDR S&P 500 ETF (SPY) at 3.95%. This indicates that CLOV's price experiences larger fluctuations and is considered to be riskier than SPY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%SeptemberOctoberNovemberDecember2025
14.49%
3.95%
CLOV
SPY
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab